Non-alcoholic fatty liver disease (NAFLD) has become an epidemic, much like other non-
communicable diseases (NCDs), such as cancer, obesity, diabetes, and cardiovascular …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide. In
some patients with NAFLD, isolated steatosis can progress to advanced stages with non …

Nonalcoholic fatty liver disease (NAFLD) has reached epidemic proportions worldwide.
NAFLD and type 2 diabetes mellitus (T2DM) are known to frequently coexist and act …

Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in patients with diabetes
mellitus and increasing evidence suggests that patients with type 2 diabetes are at a …

The global prevalence of nonalcoholic fatty liver disease (NAFLD) is rising, along with the
epidemic of diabesity. NAFLD is present in> 70% of individuals with type 2 diabetes …

Non-alcoholic fatty liver disease (NAFLD) is a public health problem worldwide. This
narrative Review provides an overview of the current literature to support the notion that …

Metabolic syndrome is a cluster of metabolic abnormalities that identifies people at risk of
diabetes and cardiovascular disease, whereas non-alcoholic fatty liver disease (NAFLD) is …

Background Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease worldwide. The increasing prevalence of NAFLD mirrors that of obesity and type 2 …

Context Nonalcoholic fatty liver disease (NAFLD) prevalence is high, especially in patients
with obesity and type 2 diabetes, and is expected to rise steeply in the coming decades …

Recent data increasingly support a complex interplay between the metabolic condition
diabetes mellitus and the pathologically defined nonalcoholic fatty liver disease (NAFLD) …